TB-500 (Thymosin Beta-4)
Compound №03 · Monograph

TB-500 (Thymosin Beta-4)

Actin-binding peptide investigated in regenerative research

Reform Medical Team
Published February 17, 2026
Educational use only

TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), an endogenous 43-amino acid protein found in virtually all human tissues. It regulates actin polymerization, enabling rapid cell migration to injury sites, and stimulates angiogenesis to restore blood flow to damaged tissue. Human clinical trials have confirmed efficacy in corneal wound healing.

Mechanism of action

Research highlights

Key researchers

Gabriel Sosne, M.D.

Wayne State University / Kresge Eye Institute

Lead expert in Tβ4 corneal repair; Annals NY Acad. Sci. (2012) review.

Hynda Kleinman, Ph.D.

NIH / National Cancer Institute

Extensive collaboration on Tβ4 in wound healing, angiogenesis, and tissue repair.

Allan Goldstein, Ph.D.

George Washington University

Original discoverer of Thymosin Beta-4.

Primary sources

Disclaimer: The compounds discussed are not intended for human or animal consumption. All information shared in this article is for educational purposes only.

More monographs

View all